HRT Financial’s Aehr Test Systems AEHR Stock Holding History

HRT Financial’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.06M	Buy	55,600 +7,400	+15%	+$237K	0.01%	1601
2025 Q4	$973K	Buy	+48,200	New	+$1.17M	﹤0.01%	1736

Other funds holding AEHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's AEHR Position: Q1 2024 in Review

HRT Financial sold out of Aehr Test Systems (AEHR) in Q1 2024, closing a stake of 41,022 shares — an estimated $1.09M sold.

HRT Financial first reported a position in AEHR in Q4 2021 and held it in 4 quarters. The position peaked at $3.43M in Q1 2023. 132 funds tracked by Wall St. Rank hold AEHR as of Q1 2024.

HRT Financial reported no remaining Aehr Test Systems position as of Q1 2024 after selling out during the quarter.
HRT Financial sold 41,022 Aehr Test Systems shares in Q1 2024, an estimated $1.09M.
HRT Financial first reported a position in Aehr Test Systems in Q4 2021 and held it in 4 quarters.
HRT Financial's Aehr Test Systems position peaked at $3.43M in Q1 2023.
132 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.